Position in NVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$94,507,947
+$14,829,846 QoQ
Shares Held
618,710
+7.1% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 86.16686331237575.ToString("F0")%
Shared 11.458356903880656.ToString("F0")%
None 2.3747797837435956.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Sep 30, 2024CallValue
$4,267,242
CallShares
37,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ROYAL BANK OF CANADA holds $17,384,840,434 across 18 Drug Manufacturers - General names. NVS ranks #14 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,262,531 | $3,920,548,130 | |
| 2 | JNJ |
Johnson & Johnson
|
13,387,402 | $3,272,416,535 | |
| 3 | AZN |
Astrazeneca PLC
|
10,386,455 | $2,048,416,647 | |
| 4 | ABBV |
AbbVie Inc.
|
7,534,148 | $1,638,601,840 | |
| 5 | MRK |
Merck & Co., Inc.
|
13,201,722 | $1,588,035,133 | |
| 6 | AMGN |
Amgen Inc
|
4,471,445 | $1,573,277,917 | |
| 7 | PFE |
Pfizer Inc
|
34,155,840 | $959,095,979 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,647,122 | $787,039,387 |
All Filings in NVS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,507,947 | 618,710 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $79,678,101 | 577,922 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $70,779,114 | 551,927 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $60,964,713 | 503,799 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $60,559,500 | 543,232 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $57,483,154 | 590,722 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,267,242 | 37,100 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $67,390,559 | 585,903 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $67,990,142 | 638,645 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $57,839,505 | 597,948 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $59,507,776 | 589,361 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $59,764,006 | 586,727 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $61,764,382 | 612,074 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $13,925,580 | 138,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $56,530,688 | 614,464 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $56,166,018 | 619,114 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $48,355,047 | 636,167 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $80,305,693 | 950,026 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $88,481,128 | 1,008,332 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $86,316,263 | 986,810 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $108,886,547 | 1,331,457 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $136,731,072 | 1,498,587 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $128,616,537 | 1,504,639 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $137,408,204 | 1,455,133 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $133,867,002 | 1,539,409 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $131,212,971 | 1,502,324 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $122,752,214 | 1,488,808 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||